文献速递眼底病与葡萄膜炎

2型糖尿病患者黄斑脉络膜厚度与需转诊糖尿病视网膜病变风险:一项2年纵向研究

Macular Choroidal Thickness and the Risk of Referable Diabetic Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2022-01-01

本研究为前瞻性队列研究,纳入中国广州30至80岁2型糖尿病患者1345例并随访2年,其中120例(8.92%)新发需转诊糖尿病视网膜病变(RDR)。校正其他因素后,平均脉络膜厚度(CT)较薄与新发RDR风险升高相关(RR=0.903,95%CI=0.871-0.935,P<0.001),加入平均CT使RDR预测的AUC从0.708升至0.761。

要点

  • 2年随访中新发需转诊糖尿病视网膜病变120例,占8.92%。
  • 校正后平均脉络膜厚度较薄与新发RDR风险升高相关,RR=0.903(95%CI=0.871-0.935)。
  • 加入平均脉络膜厚度使RDR预测AUC由0.708升至0.761,NRI为0.464±0.096。

核心结论

  • 采用扫频源光学相干断层扫描(SS-OCT)测得的脉络膜厚度变薄是需转诊糖尿病视网膜病变发生的早期影像学生物标志物,提示脉络膜厚度改变在糖尿病视网膜病变发生中起重要作用。

研究设计与样本

  • 前瞻性队列研究,纳入中国广州30至80岁2型糖尿病患者1345例,采用标准7视野眼底照相及商用SS-OCT(DRI OCT Triton;Topcon,东京,日本)测量黄斑脉络膜厚度,随访2年。

主要发现

  • 2年随访时120例(8.92%)新发需转诊糖尿病视网膜病变。
  • 校正其他因素后,新发RDR风险升高与较高的糖化血红蛋白(RR=1.35,95%CI=1.17-1.55,P<0.001)、较高的收缩压(RR=1.02,95%CI=1.01-1.03,P=0.005)、较低的甘油三酯水平(RR=0.81,95%CI=0.69-0.96,P=0.015)、存在糖尿病视网膜病变(RR=8.16,95%CI=4.47-14.89,P<0.001)及较薄的平均脉络膜厚度(RR=0.903,95%CI=0.871-0.935,P<0.001)相关。
  • 加入平均脉络膜厚度后,RDR风险的净重分类改善为0.464±0.096(P<0.001),综合判别改善为0.0321±0.0068(P<0.001),AUC从0.708(95%CI=0.659-0.757)升至0.761(95%CI=0.719-0.804)。

关键数值与推荐

  • 新发RDR风险与平均脉络膜厚度的关联:RR=0.903,95%CI=0.871-0.935,P<0.001。
  • 加入平均脉络膜厚度后RDR预测AUC从0.708(95%CI=0.659-0.757)升至0.761(95%CI=0.719-0.804)。
  • 加入平均脉络膜厚度后NRI=0.464±0.096(P<0.001),IDI=0.0321±0.0068(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study was to evaluate the associations between choroidal thickness (CT) and the 2-year incidence of referable diabetic retinopathy (RDR). METHODS: This was a prospective cohort study. Patients with type 2 diabetes in Guangzhou, China, aged 30 to 80 years underwent comprehensive examinations, including standard 7-field fundus photography. Macular CT was measured using a commercial swept-source optical coherence tomography (SS-OCT) device (DRI OCT Triton; Topcon, Tokyo, Japan). The relative risk (RR) with 95% confidence intervals (CIs) was used to quantify the association between CT and new-onset RDR. The prognostic value of CT was assessed using the area under the receiver operating characteristic curve (AUC), net reclassification improvement (NRI), and integrated discrimination improvement (IDI). RESULTS: A total of 1345 patients with diabetes were included in the study, and 120 (8.92%) of them had newly developed RDR at the 2-year follow-up. After adjusting for other factors, the increased RDR risk was associated with greater HbA1c (RR = 1.35, 95% CI = 1.17-1.55, P < 0.001), higher systolic blood pressure (SBP; RR = 1.02, 95% CI = 1.01-1.03, P = 0.005), lower triglyceride (TG) level (RR = 0.81, 95% CI = 0.69-0.96, P = 0.015), presence of diabetic retinopathy (DR; RR = 8.16, 95% CI = 4.47-14.89, P < 0.001), and thinner average CT (RR = 0.903, 95% CI = 0.871-0.935, P < 0.001). The addition of average CT improved NRI (0.464 ± 0.096, P < 0.001) and IDI (0.0321 ± 0.0068, P < 0.001) for risk of RDR, and it also improved the AUC from 0.708 (95% CI = 0.659-0.757) to 0.761 (95% CI = 0.719-0.804). CONCLUSIONS: CT thinning measured by SS-OCT is an early imaging biomarker for the development of RDR, suggesting that alterations in CT play an essential role in DR occurrence.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Wang W, Li L, Wang J, et al. Macular Choroidal Thickness and the Risk of Referable Diabetic Retinopathy in Type 2 Diabetes: A 2-Year Longitudinal Study. Invest Ophthalmol Vis Sci. 2022. PMID: 35420642. doi:10.1167/iovs.63.4.9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。